emetine has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Depierre, A; Israel, L | 1 |
| Coltman, CA; Panettiere, F | 1 |
2 other study(ies) available for emetine and Adenocarcinoma
| Article | Year |
|---|---|
[Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Emetine; Female; Fluorouracil; Humans; Immunotherapy; Lomustine; Male; Methotrexate; Middle Aged; Mitomycins; Palliative Care; Propionibacterium acnes; Vincristine | 1976 |
Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Diarrhea; Electrocardiography; Emetine; Female; Humans; Injections, Intravenous; Laryngeal Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Myositis; Nausea; Tachycardia; Thyroid Neoplasms; Tracheal Neoplasms; Urinary Bladder Neoplasms | 1971 |